Global Ultra Long Acting Insulin Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ultra Long Acting Insulin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ultra Long Acting Insulin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ultra Long Acting Insulin by Country/Region, 2017, 2022 & 2028

2.2 Ultra Long Acting Insulin Segment by Type

2.2.1 Insulin Glargine

2.2.2 Insulin Detemir

2.2.3 Tresiba

2.3 Ultra Long Acting Insulin Sales by Type

2.3.1 Global Ultra Long Acting Insulin Sales Market Share by Type (2017-2022)

2.3.2 Global Ultra Long Acting Insulin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ultra Long Acting Insulin Sale Price by Type (2017-2022)

2.4 Ultra Long Acting Insulin Segment by Application

2.4.1 Type 1 Diabetes

2.4.2 Type 2 Diabetes

2.4.3 Gestational Diabetes

2.5 Ultra Long Acting Insulin Sales by Application

2.5.1 Global Ultra Long Acting Insulin Sale Market Share by Application (2017-2022)

2.5.2 Global Ultra Long Acting Insulin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ultra Long Acting Insulin Sale Price by Application (2017-2022)

3 Global Ultra Long Acting Insulin by Company

3.1 Global Ultra Long Acting Insulin Breakdown Data by Company

3.1.1 Global Ultra Long Acting Insulin Annual Sales by Company (2020-2022)

3.1.2 Global Ultra Long Acting Insulin Sales Market Share by Company (2020-2022)

3.2 Global Ultra Long Acting Insulin Annual Revenue by Company (2020-2022)

3.2.1 Global Ultra Long Acting Insulin Revenue by Company (2020-2022)

3.2.2 Global Ultra Long Acting Insulin Revenue Market Share by Company (2020-2022)

3.3 Global Ultra Long Acting Insulin Sale Price by Company

3.4 Key Manufacturers Ultra Long Acting Insulin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ultra Long Acting Insulin Product Location Distribution

3.4.2 Players Ultra Long Acting Insulin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ultra Long Acting Insulin by Geographic Region

4.1 World Historic Ultra Long Acting Insulin Market Size by Geographic Region (2017-2022)

4.1.1 Global Ultra Long Acting Insulin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ultra Long Acting Insulin Annual Revenue by Geographic Region

4.2 World Historic Ultra Long Acting Insulin Market Size by Country/Region (2017-2022)

4.2.1 Global Ultra Long Acting Insulin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ultra Long Acting Insulin Annual Revenue by Country/Region

4.3 Americas Ultra Long Acting Insulin Sales Growth

4.4 APAC Ultra Long Acting Insulin Sales Growth

4.5 Europe Ultra Long Acting Insulin Sales Growth

4.6 Middle East & Africa Ultra Long Acting Insulin Sales Growth

5 Americas

5.1 Americas Ultra Long Acting Insulin Sales by Country

5.1.1 Americas Ultra Long Acting Insulin Sales by Country (2017-2022)

5.1.2 Americas Ultra Long Acting Insulin Revenue by Country (2017-2022)

5.2 Americas Ultra Long Acting Insulin Sales by Type

5.3 Americas Ultra Long Acting Insulin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ultra Long Acting Insulin Sales by Region

6.1.1 APAC Ultra Long Acting Insulin Sales by Region (2017-2022)

6.1.2 APAC Ultra Long Acting Insulin Revenue by Region (2017-2022)

6.2 APAC Ultra Long Acting Insulin Sales by Type

6.3 APAC Ultra Long Acting Insulin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ultra Long Acting Insulin by Country

7.1.1 Europe Ultra Long Acting Insulin Sales by Country (2017-2022)

7.1.2 Europe Ultra Long Acting Insulin Revenue by Country (2017-2022)

7.2 Europe Ultra Long Acting Insulin Sales by Type

7.3 Europe Ultra Long Acting Insulin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ultra Long Acting Insulin by Country

8.1.1 Middle East & Africa Ultra Long Acting Insulin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ultra Long Acting Insulin Revenue by Country (2017-2022)

8.2 Middle East & Africa Ultra Long Acting Insulin Sales by Type

8.3 Middle East & Africa Ultra Long Acting Insulin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ultra Long Acting Insulin

10.3 Manufacturing Process Analysis of Ultra Long Acting Insulin

10.4 Industry Chain Structure of Ultra Long Acting Insulin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ultra Long Acting Insulin Distributors

11.3 Ultra Long Acting Insulin Customer

12 World Forecast Review for Ultra Long Acting Insulin by Geographic Region

12.1 Global Ultra Long Acting Insulin Market Size Forecast by Region

12.1.1 Global Ultra Long Acting Insulin Forecast by Region (2023-2028)

12.1.2 Global Ultra Long Acting Insulin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ultra Long Acting Insulin Forecast by Type

12.7 Global Ultra Long Acting Insulin Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Ultra Long Acting Insulin Product Offered

13.1.3 Sanofi Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Eli Lilly

13.2.1 Eli Lilly Company Information

13.2.2 Eli Lilly Ultra Long Acting Insulin Product Offered

13.2.3 Eli Lilly Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly Main Business Overview

13.2.5 Eli Lilly Latest Developments

13.3 Viatris

13.3.1 Viatris Company Information

13.3.2 Viatris Ultra Long Acting Insulin Product Offered

13.3.3 Viatris Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Viatris Main Business Overview

13.3.5 Viatris Latest Developments

13.4 Gan&Lee Pharmaceuticals

13.4.1 Gan&Lee Pharmaceuticals Company Information

13.4.2 Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Product Offered

13.4.3 Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Gan&Lee Pharmaceuticals Main Business Overview

13.4.5 Gan&Lee Pharmaceuticals Latest Developments

13.5 Tonghua Dongbao Pharmaceutical

13.5.1 Tonghua Dongbao Pharmaceutical Company Information

13.5.2 Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Product Offered

13.5.3 Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Tonghua Dongbao Pharmaceutical Main Business Overview

13.5.5 Tonghua Dongbao Pharmaceutical Latest Developments

13.6 United Laboratories International

13.6.1 United Laboratories International Company Information

13.6.2 United Laboratories International Ultra Long Acting Insulin Product Offered

13.6.3 United Laboratories International Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 United Laboratories International Main Business Overview

13.6.5 United Laboratories International Latest Developments

13.7 Novo Nordisk

13.7.1 Novo Nordisk Company Information

13.7.2 Novo Nordisk Ultra Long Acting Insulin Product Offered

13.7.3 Novo Nordisk Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novo Nordisk Main Business Overview

13.7.5 Novo Nordisk Latest Developments

13.8 MNKD

13.8.1 MNKD Company Information

13.8.2 MNKD Ultra Long Acting Insulin Product Offered

13.8.3 MNKD Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 MNKD Main Business Overview

13.8.5 MNKD Latest Developments

13.9 Bristol-Myers Squibb Company

13.9.1 Bristol-Myers Squibb Company Company Information

13.9.2 Bristol-Myers Squibb Company Ultra Long Acting Insulin Product Offered

13.9.3 Bristol-Myers Squibb Company Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bristol-Myers Squibb Company Main Business Overview

13.9.5 Bristol-Myers Squibb Company Latest Developments

13.10 Emisphere

13.10.1 Emisphere Company Information

13.10.2 Emisphere Ultra Long Acting Insulin Product Offered

13.10.3 Emisphere Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Emisphere Main Business Overview

13.10.5 Emisphere Latest Developments

13.11 Biocon

13.11.1 Biocon Company Information

13.11.2 Biocon Ultra Long Acting Insulin Product Offered

13.11.3 Biocon Ultra Long Acting Insulin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Biocon Main Business Overview

13.11.5 Biocon Latest Developments

14 Research Findings and Conclusion

Table 1. Ultra Long Acting Insulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ultra Long Acting Insulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Insulin Glargine

Table 4. Major Players of Insulin Detemir

Table 5. Major Players of Tresiba

Table 6. Global Ultra Long Acting Insulin Sales by Type (2017-2022) & (K Units)

Table 7. Global Ultra Long Acting Insulin Sales Market Share by Type (2017-2022)

Table 8. Global Ultra Long Acting Insulin Revenue by Type (2017-2022) & ($ million)

Table 9. Global Ultra Long Acting Insulin Revenue Market Share by Type (2017-2022)

Table 10. Global Ultra Long Acting Insulin Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Ultra Long Acting Insulin Sales by Application (2017-2022) & (K Units)

Table 12. Global Ultra Long Acting Insulin Sales Market Share by Application (2017-2022)

Table 13. Global Ultra Long Acting Insulin Revenue by Application (2017-2022)

Table 14. Global Ultra Long Acting Insulin Revenue Market Share by Application (2017-2022)

Table 15. Global Ultra Long Acting Insulin Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Ultra Long Acting Insulin Sales by Company (2020-2022) & (K Units)

Table 17. Global Ultra Long Acting Insulin Sales Market Share by Company (2020-2022)

Table 18. Global Ultra Long Acting Insulin Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Ultra Long Acting Insulin Revenue Market Share by Company (2020-2022)

Table 20. Global Ultra Long Acting Insulin Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Ultra Long Acting Insulin Producing Area Distribution and Sales Area

Table 22. Players Ultra Long Acting Insulin Products Offered

Table 23. Ultra Long Acting Insulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Ultra Long Acting Insulin Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Ultra Long Acting Insulin Sales Market Share Geographic Region (2017-2022)

Table 28. Global Ultra Long Acting Insulin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Ultra Long Acting Insulin Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Ultra Long Acting Insulin Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Ultra Long Acting Insulin Sales Market Share by Country/Region (2017-2022)

Table 32. Global Ultra Long Acting Insulin Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Ultra Long Acting Insulin Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Ultra Long Acting Insulin Sales by Country (2017-2022) & (K Units)

Table 35. Americas Ultra Long Acting Insulin Sales Market Share by Country (2017-2022)

Table 36. Americas Ultra Long Acting Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Ultra Long Acting Insulin Revenue Market Share by Country (2017-2022)

Table 38. Americas Ultra Long Acting Insulin Sales by Type (2017-2022) & (K Units)

Table 39. Americas Ultra Long Acting Insulin Sales Market Share by Type (2017-2022)

Table 40. Americas Ultra Long Acting Insulin Sales by Application (2017-2022) & (K Units)

Table 41. Americas Ultra Long Acting Insulin Sales Market Share by Application (2017-2022)

Table 42. APAC Ultra Long Acting Insulin Sales by Region (2017-2022) & (K Units)

Table 43. APAC Ultra Long Acting Insulin Sales Market Share by Region (2017-2022)

Table 44. APAC Ultra Long Acting Insulin Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Ultra Long Acting Insulin Revenue Market Share by Region (2017-2022)

Table 46. APAC Ultra Long Acting Insulin Sales by Type (2017-2022) & (K Units)

Table 47. APAC Ultra Long Acting Insulin Sales Market Share by Type (2017-2022)

Table 48. APAC Ultra Long Acting Insulin Sales by Application (2017-2022) & (K Units)

Table 49. APAC Ultra Long Acting Insulin Sales Market Share by Application (2017-2022)

Table 50. Europe Ultra Long Acting Insulin Sales by Country (2017-2022) & (K Units)

Table 51. Europe Ultra Long Acting Insulin Sales Market Share by Country (2017-2022)

Table 52. Europe Ultra Long Acting Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Ultra Long Acting Insulin Revenue Market Share by Country (2017-2022)

Table 54. Europe Ultra Long Acting Insulin Sales by Type (2017-2022) & (K Units)

Table 55. Europe Ultra Long Acting Insulin Sales Market Share by Type (2017-2022)

Table 56. Europe Ultra Long Acting Insulin Sales by Application (2017-2022) & (K Units)

Table 57. Europe Ultra Long Acting Insulin Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Ultra Long Acting Insulin Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Ultra Long Acting Insulin Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Ultra Long Acting Insulin Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Ultra Long Acting Insulin Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Ultra Long Acting Insulin Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Ultra Long Acting Insulin Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Ultra Long Acting Insulin Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Ultra Long Acting Insulin Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Ultra Long Acting Insulin

Table 67. Key Market Challenges & Risks of Ultra Long Acting Insulin

Table 68. Key Industry Trends of Ultra Long Acting Insulin

Table 69. Ultra Long Acting Insulin Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Ultra Long Acting Insulin Distributors List

Table 72. Ultra Long Acting Insulin Customer List

Table 73. Global Ultra Long Acting Insulin Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Ultra Long Acting Insulin Sales Market Forecast by Region

Table 75. Global Ultra Long Acting Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Ultra Long Acting Insulin Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Ultra Long Acting Insulin Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Ultra Long Acting Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Ultra Long Acting Insulin Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Ultra Long Acting Insulin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Ultra Long Acting Insulin Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Ultra Long Acting Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Ultra Long Acting Insulin Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Ultra Long Acting Insulin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Ultra Long Acting Insulin Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Ultra Long Acting Insulin Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Ultra Long Acting Insulin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Ultra Long Acting Insulin Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Ultra Long Acting Insulin Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Ultra Long Acting Insulin Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Ultra Long Acting Insulin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Ultra Long Acting Insulin Revenue Market Share Forecast by Application (2023-2028)

Table 93. Sanofi Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Ultra Long Acting Insulin Product Offered

Table 95. Sanofi Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Eli Lilly Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 99. Eli Lilly Ultra Long Acting Insulin Product Offered

Table 100. Eli Lilly Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Eli Lilly Main Business

Table 102. Eli Lilly Latest Developments

Table 103. Viatris Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 104. Viatris Ultra Long Acting Insulin Product Offered

Table 105. Viatris Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Viatris Main Business

Table 107. Viatris Latest Developments

Table 108. Gan&Lee Pharmaceuticals Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 109. Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Product Offered

Table 110. Gan&Lee Pharmaceuticals Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Gan&Lee Pharmaceuticals Main Business

Table 112. Gan&Lee Pharmaceuticals Latest Developments

Table 113. Tonghua Dongbao Pharmaceutical Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 114. Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Product Offered

Table 115. Tonghua Dongbao Pharmaceutical Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Tonghua Dongbao Pharmaceutical Main Business

Table 117. Tonghua Dongbao Pharmaceutical Latest Developments

Table 118. United Laboratories International Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 119. United Laboratories International Ultra Long Acting Insulin Product Offered

Table 120. United Laboratories International Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. United Laboratories International Main Business

Table 122. United Laboratories International Latest Developments

Table 123. Novo Nordisk Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 124. Novo Nordisk Ultra Long Acting Insulin Product Offered

Table 125. Novo Nordisk Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Novo Nordisk Main Business

Table 127. Novo Nordisk Latest Developments

Table 128. MNKD Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 129. MNKD Ultra Long Acting Insulin Product Offered

Table 130. MNKD Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. MNKD Main Business

Table 132. MNKD Latest Developments

Table 133. Bristol-Myers Squibb Company Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 134. Bristol-Myers Squibb Company Ultra Long Acting Insulin Product Offered

Table 135. Bristol-Myers Squibb Company Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Bristol-Myers Squibb Company Main Business

Table 137. Bristol-Myers Squibb Company Latest Developments

Table 138. Emisphere Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 139. Emisphere Ultra Long Acting Insulin Product Offered

Table 140. Emisphere Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Emisphere Main Business

Table 142. Emisphere Latest Developments

Table 143. Biocon Basic Information, Ultra Long Acting Insulin Manufacturing Base, Sales Area and Its Competitors

Table 144. Biocon Ultra Long Acting Insulin Product Offered

Table 145. Biocon Ultra Long Acting Insulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Biocon Main Business

Table 147. Biocon Latest Developments

List of Figures

Figure 1. Picture of Ultra Long Acting Insulin

Figure 2. Ultra Long Acting Insulin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ultra Long Acting Insulin Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Ultra Long Acting Insulin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ultra Long Acting Insulin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Insulin Glargine

Figure 10. Product Picture of Insulin Detemir

Figure 11. Product Picture of Tresiba

Figure 12. Global Ultra Long Acting Insulin Sales Market Share by Type in 2021

Figure 13. Global Ultra Long Acting Insulin Revenue Market Share by Type (2017-2022)

Figure 14. Ultra Long Acting Insulin Consumed in Type 1 Diabetes

Figure 15. Global Ultra Long Acting Insulin Market: Type 1 Diabetes (2017-2022) & (K Units)

Figure 16. Ultra Long Acting Insulin Consumed in Type 2 Diabetes

Figure 17. Global Ultra Long Acting Insulin Market: Type 2 Diabetes (2017-2022) & (K Units)

Figure 18. Ultra Long Acting Insulin Consumed in Gestational Diabetes

Figure 19. Global Ultra Long Acting Insulin Market: Gestational Diabetes (2017-2022) & (K Units)

Figure 20. Global Ultra Long Acting Insulin Sales Market Share by Application (2017-2022)

Figure 21. Global Ultra Long Acting Insulin Revenue Market Share by Application in 2021

Figure 22. Ultra Long Acting Insulin Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Ultra Long Acting Insulin Revenue Market Share by Company in 2021

Figure 24. Global Ultra Long Acting Insulin Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Ultra Long Acting Insulin Revenue Market Share by Geographic Region in 2021

Figure 26. Global Ultra Long Acting Insulin Sales Market Share by Region (2017-2022)

Figure 27. Global Ultra Long Acting Insulin Revenue Market Share by Country/Region in 2021

Figure 28. Americas Ultra Long Acting Insulin Sales 2017-2022 (K Units)

Figure 29. Americas Ultra Long Acting Insulin Revenue 2017-2022 ($ Millions)

Figure 30. APAC Ultra Long Acting Insulin Sales 2017-2022 (K Units)

Figure 31. APAC Ultra Long Acting Insulin Revenue 2017-2022 ($ Millions)

Figure 32. Europe Ultra Long Acting Insulin Sales 2017-2022 (K Units)

Figure 33. Europe Ultra Long Acting Insulin Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Ultra Long Acting Insulin Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Ultra Long Acting Insulin Revenue 2017-2022 ($ Millions)

Figure 36. Americas Ultra Long Acting Insulin Sales Market Share by Country in 2021

Figure 37. Americas Ultra Long Acting Insulin Revenue Market Share by Country in 2021

Figure 38. United States Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Ultra Long Acting Insulin Sales Market Share by Region in 2021

Figure 43. APAC Ultra Long Acting Insulin Revenue Market Share by Regions in 2021

Figure 44. China Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Ultra Long Acting Insulin Sales Market Share by Country in 2021

Figure 51. Europe Ultra Long Acting Insulin Revenue Market Share by Country in 2021

Figure 52. Germany Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Ultra Long Acting Insulin Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Ultra Long Acting Insulin Revenue Market Share by Country in 2021

Figure 59. Egypt Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Ultra Long Acting Insulin Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Ultra Long Acting Insulin in 2021

Figure 65. Manufacturing Process Analysis of Ultra Long Acting Insulin

Figure 66. Industry Chain Structure of Ultra Long Acting Insulin

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles